Reduced Levels of Lacrimal Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Patients with Focal Epilepsy and Focal Epilepsy with Comorbid Depression: A Biomarker Candidate?

Alexander A. Shpak; Flora K. Rider; Tatiana A. Druzhkova; Marina Y. Zhanina; Sofya B. Popova; Alla B. Guekht; Natalia V. Gulyaeva

doi:10.20944/preprints202310.1525.v1

Preprint

Article

Reduced Levels of Lacrimal Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Patients with Focal Epilepsy and Focal Epilepsy with Comorbid Depression: A Biomarker Candidate?

This version is not peer-reviewed.

Altmetrics

Downloads

104

Views

Comments

Submitted:

20 October 2023

Posted:

24 October 2023

You are already at the latest version

A peer-reviewed article of this preprint also exists.

Abstract

Keywords:

Subject:

Medicine and Pharmacology - Neuroscience and Neurology

Supplementary Material

supplementary.docx (748.23KB )

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.

Alerts

MDPI Initiatives

Important Links

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

Disclaimer

Reduced Levels of Lacrimal Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Patients with Focal Epilepsy and Focal Epilepsy with Comorbid Depression: A Biomarker Candidate?

Abstract

Keywords:

Subject:

MDPI Initiatives

Important Links

Subscribe